Clinical trial
Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy…
NCT00406289 · University Hospital, Ghent, Other · Completed
Key facts
| NCT number | NCT00406289 |
|---|---|
| Title | Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor |
| Official title | Phase I Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) With Patients With Head and Neck Tumor |
| Lead sponsor | University Hospital, Ghent, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Head and Neck Tumor |
| Intervention type | Procedure |
| Interventions | 18F-FDG-PET radiotherapy |
| Enrollment | 24 |
| Start date | Nov 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Feb 1, 2010 |
| First posted | Dec 4, 2006 |
| Last update posted | Sep 6, 2010 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: